Cure My Disease

Don't miss your cure!

 Log in / Sign up

Blood test could detect hidden pancreatic tumors

NCT ID NCT05847855

Recruiting now Diagnosis Sponsor: Fudan University Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing a new blood test that looks at fragments of DNA to find pancreatic neuroendocrine tumors early and tell them apart from other pancreatic tumors. Researchers will collect blood from 1,000 adults with different types of pancreatic tumors to see how accurate the test is. If it works, it could lead to earlier detection and better treatment decisions.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this blood test could help doctors find pancreatic neuroendocrine tumors earlier and avoid unnecessary surgeries by distinguishing tumor types.
What could go wrong
This is an early diagnostic study, not a treatment. The test may not be accurate enough in real-world settings, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC DUCTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Adenoma, Islet Cell pancreatic ductal adenocarcinoma pancreatic neoplasm pancreatic neuroendocrine tumor solid pseudopapillary neoplasm of the pancreas

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PANCREATIC NEUROENDOCRINE TUMOR SOLID PANCREATIC NEOPLASMS

Contacts and locations

Locations

  • Fudan University shanghai cancer center

    RECRUITING

    Shanghai, Shanghai Municipality, 200032, China

  • West China Hospital, Sichuan University

    RECRUITING

    Chengdu, Sichuan, 610041, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.